Vera Therapeutics, Inc. - CL A (VERA)

Q3 2024 13F Holders as of 9/30/2024

Type / Class
Equity / CL A
Number of holders
172
Total Shares
53.5M
Shares change
-421K
Total reported value, excl. options
$2.37B
Value change
-$1.77M
Put/Call ratio
1.16
Number of buys
92
Number of sells
-74
Price
$44.20
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.